Overwhelming demand for transformative GLP-1 agonists like Ozempic and Mounjaro has led to widespread compounding and a boom in counterfeiting.

Is it safe or cost-effective to import medicine from Canada's or other countries' drug supplies?

 

Pharmacy to pharmacy marketplaces for medicine have been used to traffick counterfeits. PSM is urging better safety measures

State Prescription Drug Affordability Boards intend to control medicine costs — but some of their strategies will have unintended consequences.

After two decades of tracking counterfeit drugs, PSM is an expert on medicine safety issues and we often offer journalists our insight and perspective. 

June 2, 2025: FDA continues to protect Americans from unapproved and contaminated medicine

June 2, 2025
A website called Proximo Research showing a gloved hand and a flask of greenish liquid

The FDA warned companies over the sale of an unapproved medical device and contaminated eye medicines, and disbarred a Texan who sold illegally imported pharmaceuticals.

FDA Alert: Nationwide recall of Unavy and Umovy supplements for undeclared drug ingredients

May 28, 2025
Bottles of products under recall

The FDA has announced a voluntary nationwide recall of two dietary supplements sold exclusively online by www.umary-usa.com. Lab testing revealed that Unavy Ácido HIALURÓNICO and Umovy Ácido HIALURÓNICO contain undeclared active pharmaceutical ingredients: diclofenac, dexamethasone, and omeprazole.

The End of GLP-1 Compounding

May 27, 2025

Federally-registered compounding facilities stopped making tirzepatide on May 22. This transition is significant for patients, and we at PSM think there are four things you should be watching for.

May 27, 2025: Global effort to disrupt darknet marketplaces yields 4,400 pounds of illicit drugs.

May 27, 2025

Operation RapTor led to 270 arrests and the seizure of more than $200 million in currency and digital assets.

Empower Pharmacy’s no good, very bad week.

May 21, 2025

Articles in Endpoints News and the Houston Chronicle raise questions about the regulatory process for 503B compounding facilities.

May 19, 2025: Investigations raise questions about product safety at a Texas compounding company

May 20, 2025

Exposes in the Houston Chronicle and Endpoints News examined Empower Pharmacy’s safety record. A grand jury indicted a Chinese company and three of its employees for pill press and counterfeit die mold sales.

May 12, 2025: FDA will expand unannounced foreign facility inspections, it says

May 12, 2025

The FDA wants to ensure that domestic and foreign companies receive the same level of regulatory oversight.

Catch up on research PSM released about medicines imported from unregistered sources.

Like your information on video? Subscribe to our YouTube playlist!

Updates on two federal prosecutions.

youtube-video-thumbnail
youtube-video-thumbnail

DrXanax's empire spanned years and nearly every U.S. state.

Click the images below to see more recent videos.